Literature DB >> 9021160

Mapping of the Simpson-Golabi-Behmel overgrowth syndrome gene (GPC3) to chromosome X in human and rat by fluorescence in situ hybridization.

T Shen1, G Sonoda, J Hamid, M Li, J Filmus, R N Buick, J R Testa.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9021160     DOI: 10.1007/s003359900357

Source DB:  PubMed          Journal:  Mamm Genome        ISSN: 0938-8990            Impact factor:   2.957


× No keyword cloud information.
  5 in total

1.  Localization of the interferon-alpha gene cluster to rat chromosome bands 5q31----q33 by fluorescence in situ hybridization.

Authors:  J R Testa; T Taguchi; A G Knudson; O Hino
Journal:  Cytogenet Cell Genet       Date:  1992

2.  Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine.

Authors:  J Filmus; J G Church; R N Buick
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

3.  Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome.

Authors:  G Pilia; R M Hughes-Benzie; A MacKenzie; P Baybayan; E Y Chen; R Huber; G Neri; A Cao; A Forabosco; D Schlessinger
Journal:  Nat Genet       Date:  1996-03       Impact factor: 38.330

Review 4.  Integral membrane heparan sulfate proteoglycans.

Authors:  G David
Journal:  FASEB J       Date:  1993-08       Impact factor: 5.191

5.  Mapping of Simpson-Golabi-Behmel syndrome to Xq25-q27.

Authors:  J Y Xuan; A Besner; M Ireland; R M Hughes-Benzie; A E MacKenzie
Journal:  Hum Mol Genet       Date:  1994-01       Impact factor: 6.150

  5 in total
  2 in total

Review 1.  Therapeutic potential of targeting glypican-3 in hepatocellular carcinoma.

Authors:  Mark Allegretta; Jorge Filmus
Journal:  Anticancer Agents Med Chem       Date:  2011-07       Impact factor: 2.505

2.  Methylation analysis of the glypican 3 gene in embryonal tumours.

Authors:  G Boily; Z Saikali; D Sinnett
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.